Xintao Huang

Xintao Huang

Auto-generated profile, based on publicly available information

Xintao Huang

Department of Neurosurgery, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2013 in Journal of Neurotrauma
Verified
Journal Article
Closed access
XHXin-Tao Huang
Xin-Tao Huang
YZYong-Qiang Zhang
Yong-Qiang Zhang
SLSheng-Jie Li
Sheng-Jie Li
SLSheng-Hui Li
Sheng-Hui Li
QTQing Tang
Qing Tang
JZJianning Zhang
Jianning Zhang
Endothelial progenitor cells (EPCs) play a key role in tissue repair and regeneration. Previous studies have shown a positive correlation between the number of circulating EPCs and clinical outcomes of patients with traumatic brain injury (TBI). A recent study has further shown that intravenous infusion of human umbilical cord blood-derived endothelial colony-forming cells (ECFCs) improves outcomes of mice subjected to experimental TBI. This follow-up study was designed to determine whether intracerebroventricular (i.c.v.) infusion of ECFCs, which may reduce systemic effects of these cells, could repair the blood–brain barrier (BBB) and promote angiogenesis of mice with TBI. Adult nude mice were exposed to fluid percussion injury and transplanted i.c.v. with ECFCs on day 1 post-TBI. These ECFCs were detected at the TBI zone 3 days after transplantation by SP-DiIC 18 (3) and fluorescence in situ hybridization. Mice with ECFCs transplant had reduced Evans blue extravasation and brain water content, increased expression of ZO-1 and claudin-5, and showed a higher expression of angiopoietin 1. Consistent with the previous report, mice with ECFCs transplant had also increased microvascular density. Modified neurological severity score and Morris water maze test indicated significant improvements in motor ability, spatial acquisition and reference memory in mice receiving ECFCs, compared to those receiving saline. These data demonstrate the beneficial effects of ECFC transplant on BBB integrity and angiogenesis in mice with TBI.

1 November 2013 in Journal of Surgical Research
Verified
Journal Article
Closed access
YZYongqiang Zhang
Yongqiang Zhang
YLYing Li
Ying Li
SWShaobo Wang
Shaobo Wang
ZHZhenying Han
Zhenying Han
XHXintao Huang
Xintao Huang
JZJianning Zhang
Jianning Zhang

1 December 2014 in Brain Research
Verified
Journal Article
Closed access
SLShengjie Li
Shengjie Li
YTYe Tian
Ye Tian
XHXintao Huang
Xintao Huang
YZYongqiang Zhang
Yongqiang Zhang
DWDehui Wang
Dehui Wang
JZJianning Zhang
Jianning Zhang

1 January 2019 in Anti-Cancer Drugs
Verified
Journal Article
Open access
WHWang Hongqin
Wang Hongqin
SRShuxian Ren
Shuxian Ren
YXYongming Xu
Yongming Xu
WMWang Miao
Wang Miao
XHXintao Huang
Xintao Huang
PKPengzhou Kong
Pengzhou Kong
A double-strand breaks in the G1 and S phases. However, endogenous or acquired resistance to TMZ limits glioma patients’ clinical outcome and is also an important cause of glioma replase. MicroRNA-195 (miR-195) plays an important role in the regulation of G1-phase/S-phase transition, DNA damage repair, and apoptosis of tumor cells. We found that miR-195 expression was significantly decreased in TMZ-resistant glioma cells induced with TMZ and correlated to the resistance index negatively. Also, the exogenous expression of miR-195 reversed TMZ resistance and induced the apoptosis of TMZ-resistant glioblastoma cells. Further bioinformatics analysis showed cyclin E1 (CCNE1) was a potential target gene of miR-195. Knockdown of CCNE1 partially reversed the effect of decreased miR-195 on TMZ resistance. The data from The Cancer Genome Atlas – Cancer Genome further suggested that hsa-miR-195 could negatively regulate the expression of CCNE1 in glioma. In conclusion, miR-195 reverses the resistance to TMZ by targeting CCNE1 in glioma cells and it could act as a potential target for treatment in glioma with TMZ resistance....

14 October 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
XZXiaoshan Zhao
Xiaoshan Zhao
YYYankui Yi
Yankui Yi
CJCuiping Jiang
Cuiping Jiang
XHXintao Huang
Xintao Huang
XWXiaomin Wen
Xiaomin Wen
DPDongmei Pan
Dongmei Pan

18 April 2023 in Frontiers in Neuroscience
Verified
Journal Article
Open access
XHXintao Huang
Xintao Huang
XXXinjuan Xu
Xinjuan Xu
CWCe Wang
Ce Wang
YWYi Wang
Yi Wang
YYYajun Yang
Yajun Yang
PLPanpan Li
Panpan Li
Introduction: Traumatic brain injury (TBI) is considered the most common traumatic neurological disease, is associated with high mortality and long-term complications, and is a global public health issue. However, there has been little progress in serum markers for TBI research. Therefore, there is an urgent need for biomarkers that can sufficiently function in TBI diagnosis and evaluation.Methods: Exosomal microRNA (ExomiR), a stable circulating marker in the serum, has aroused widespread interest among researchers. To explore the level of serum ExomiR after TBI, we quantified ExomiR expression levels in serum exosomes extracted from patients with TBI using next-generation sequencing (NGS) and explored potential biomarkers using bioinformatics screening.Results: Compared with the control group, there were 245 ExomiR (136 up-regulated and 109 down-regulated) in the serum of the TBI group that changed significantly. We observed serum ExomiRs expression profiles associated with neurovascular remodeling, the integrity of the blood-brain barrier, neuroinflammation, and a cascade of secondary injury, including eight up-regulated ExomiRs (ExomiR-124-3p, ExomiR-137-3p, ExomiR-9-3p, ExomiR-133a-5p, ExomiR-204-3p, ExomiR-519a-5p, ExomiR-4732-5p, and ExomiR-206) and 2 down-regulated ExomiR (ExomiR-21-3p and ExomiR-199a-5).Discussion: The results revealed that serum ExomiRs might become a new research direction and breakthrough for the diagnosis and pathophysiological treatment of patients with TBI.